FindTrial
Sign In

Effect of Progesterone on pregnancy prolongation among women with Placenta Previa - A Randomized Controlled trial

Effect of Progesterone on pregnancy prolongation among women with Placenta Previa - A Randomized Controlled trial - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/058751
Enrollment
60
Registered
2023-10-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O098- Supervision of other high risk pregnancies

Interventions

Intervention1: weekly administration of intramuscular 17 oh progesterone: weekly administration of intramuscular 17 oh progesterone to pregnant women with placenta praevia or low lying placenta with g

Sponsors

JIPMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.pregnant female > 18 years diagnosed to have placenta previa or low lying placenta previa 2.gestational age between 28-34 weeks 3.hemodynamically stable and planned for conservative management.

Exclusion criteria

Exclusion criteria: 1.multiple pregnancies 2.uterine malformations 3.placenta acreta 4. iud of fetus 5. women already on im inj 17 oh- progesterone at time of recruitment delivery required due to other causes such as htn, growth restriction

Design outcomes

Primary

MeasureTime frame
To see prolongation of pregnancyTimepoint: To see prolongation of pregnancy—

Secondary

MeasureTime frame
better neonatal outcome due to prolongation of pregnancyTimepoint: better neonatal outcome due to prolongation of pregnancy—

Countries

India

Contacts

Public ContactDr Dilip Kumar Maurya

JIPMER, puducherry.

dilipkumar@jipmer.ac.in9442136037

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026